(Q33335722)

25 July 2017

1 reference

title

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

0 references

1 reference

1 reference

Follis F

1

1 reference

25 July 2017

Schmidt CA

series ordinal

2

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

The Annals of Thoracic Surgery

25 July 2017

published in

1 reference

25 July 2017

volume

70

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

2173-2181

1 reference

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Case 5--1996. Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Low-molecular-weight heparin in extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Protamine reversal of anticoagulation achieved with a low molecular weight heparin. The effects on eicosanoids, clotting and complement factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Anticoagulation and hemostasis in cardiac surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Assay of heparin in plasma using a chromogenic substrate for activated factor X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Quantitative determination of hirudin in blood and body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

The proteolytic action of Arvin on human fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Defibrinogenation as an alternative to heparinization during prolonged extracorporeal circulation in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Can heparin cause adult respiratory distress syndrome by a similar mechanism as heparin-associated thrombocytopenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Transient global amnesia associated with acute heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparin-associated thrombocytopenia syndrome: an underestimated etiology of adrenal hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Cardiopulmonary bypass with a low-molecular-weight heparin fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Extracorporeal circulation in a patient with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparin-induced thrombocytopenia: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Intraoperative management of patients with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Iloprost (Ilomedine) and extracorporeal circulation with conventional heparinization in a patient with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparinless cardiopulmonary bypass with ancrod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Heparin-induced thrombocytopenia and heart operation: management with tedelparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Cardiopulmonary bypass for heparin-induced thrombocytopenia: management with a heparin-bonded circuit and enoxaparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

7 January 2021

inferred from DOI database lookup

Adrenal hemorrhagic necrosis related to heparinassociated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

7 January 2021

inferred from DOI database lookup

Extracorporeal circulation in a patient with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901329-1

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0003-4975(00)01329-1

1 reference

release_wveobkajc5adjflkjt4uskxqui

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wveobkajc5adjflkjt4uskxqui

24 November 2022

mapped directly with Wikidata item

1 reference